FDA advisory panel approves new drug for lupus, Benlysta - Los Angeles Times

The Money Times

FDA advisory panel approves new drug for lupus, Benlysta Los Angeles Times Systemic lupus erythematosus, commonly known as SLE or simply lupus, is a chronic inflammatory disease that occurs when the body's immune system attacks its ... New Drug for Lupus Shown Green Signal by FDA Advisory PanelTopNews United Kingdom all 793 news articles »